10.09

0.20% 0.02

Tyra Biosciences Inc (TYRA)

Overview News Price History Option Chain Financials Discussions Forecast

Tyra Biosciences Inc stock is traded at $10.09, with a volume of 394.07K. It is up +0.20% in the last 24 hours and up +27.40% over the past month. Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Previous Close:

$10.07

Open:

$10.04

24h Volume:

394.07K

Relative Volume:

1.23

Market Cap:

$576.56M

Revenue:

Net Income/Loss:

$-83.74M

P/E Ratio:

-6.2671

EPS:

-1.61

Net Cash Flow:

$-64.98M

1W Performance:

-7.09%

1M Performance:

+27.40%

6M Performance:

-37.37%

1Y Performance:

-43.19%

1-Day Range:

$9.84

$10.73

1-Week Range:

$8.80

$10.99

52-Week Range:

$6.42

$29.60

Tyra Biosciences Inc Stock (TYRA) Company Profile

Name

Tyra Biosciences Inc

Sector

Healthcare (1153)

Industry

Biotechnology (676)

Phone

(619) 728-4760

Address

2656 STATE STREET, CARLSBAD

Employee

Twitter

Next Earnings Date

2025-03-26

Latest SEC Filings

TYRA's Discussions on Twitter

Compare TYRA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TYRA Tyra Biosciences Inc	10.09	576.56M	0	-83.74M	-64.98M	-1.61
VRTX Vertex Pharmaceuticals Inc	424.99	128.84B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	527.78	65.38B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	549.65	39.67B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.15	33.82B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	231.99	27.60B	3.81B	-644.79M	-669.77M	-6.24

Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-07-25	Initiated	UBS	Buy
Oct-18-24	Upgrade	BofA Securities	Neutral → Buy
Aug-15-24	Initiated	Piper Sandler	Overweight
Dec-15-23	Downgrade	BofA Securities	Buy → Neutral
Jun-30-23	Initiated	Wedbush	Outperform
Feb-03-23	Initiated	Oppenheimer	Outperform
Jun-23-22	Initiated	H.C. Wainwright	Buy
Mar-08-22	Upgrade	Jefferies	Hold → Buy
Nov-08-21	Downgrade	Jefferies	Buy → Hold
Oct-11-21	Initiated	BofA Securities	Buy
Oct-11-21	Initiated	Cowen	Outperform
Oct-11-21	Initiated	Jefferies	Buy

View All

Tyra Biosciences Inc Stock (TYRA) Latest News

May 09, 2025

Tyra Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 09, 2025

One Tyra Biosciences Insider Raised Stake By 284% In Previous Year - Yahoo Finance

May 09, 2025

Barclays PLC Grows Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

May 09, 2025

May 08, 2025

Kaskela Law LLC Announces Investigation of Tyra Biosciences, Inc. (NASDAQ:TYRA) and Encourages Investors to Contact the Firm for Additional Information - ACCESS Newswire

May 08, 2025

Tyra Biosciences (TYRA) Secures Financial Stability for Oncology Advancements | TYRA Stock News - GuruFocus

May 08, 2025

Tyra Biosciences Reports First Quarter 2025 Financial Results and Highlights - Yahoo Finance

May 08, 2025

May 07, 2025

Analytical Lens: Exploring Tyra Biosciences Inc (TYRA)’s Financial Story Through Ratios - DWinneX

May 07, 2025

54,783 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Acquired by Raymond James Financial Inc. - Defense World

May 07, 2025

May 05, 2025

29,100 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Bought by Renaissance Technologies LLC - Defense World

May 05, 2025

May 01, 2025

Tyra Biosciences (TYRA) to Release Earnings on Thursday - Defense World

May 01, 2025

Apr 27, 2025

Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by JPMorgan Chase & Co. - Defense World

Apr 27, 2025

Apr 26, 2025

Russell Investments Group Ltd. Acquires 10,447 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Apr 26, 2025

Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025

Geode Capital Management LLC Has $7.20 Million Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Apr 25, 2025

Apr 24, 2025